An intriguing mystery about tryptophan 2,3-dioxygenase is its hydrogen peroxide-triggered enzyme reactivation from the resting ferric oxidation state to the catalytically active ferrous form. In this study, we found that such an odd Fe(III) reduction by an oxidant depends on the presence of L-Trp, which ultimately serves as the reductant for the enzyme. In the peroxide reaction with tryptophan 2,3-dioxygenase, a previously unknown catalase-like activity was detected. A ferryl species (␦ ؍ 0.055 mm/s and ⌬E Q ؍ 1.755 mm/s) and a protein-based free radical (g ؍ 2.0028 and 1.72 millitesla linewidth) were characterized by Mössbauer and EPR spectroscopy, respectively. This is the first compound ES-type of ferryl intermediate from a heme-based dioxygenase characterized by EPR and Mössbauer spectroscopy. Density functional theory calculations revealed the contribution of secondary ligand sphere to the spectroscopic properties of the ferryl species. In the presence of L-Trp, the reactivation was demonstrated by enzyme assays and by various spectroscopic techniques. A Trp-Trp dimer and a monooxygenated L-Trp were both observed as the enzyme reactivation byproducts by mass spectrometry. Together, these results lead to the unraveling of an over 60-year old mystery of peroxide reactivation mechanism. These results may shed light on how a metalloenzyme maintains its catalytic activity in an oxidizing environment.Hemoproteins perform a wide range of biological functions, including oxygen transport, storage, electron transfer, monooxygenation, and reduction of dioxygen. However, they rarely express dioxygenase activity as their native biological function. Tryptophan 2,3-dioxygenase (TDO) 3 is the first described exception (1-3). This enzyme employs a b-type ferrous heme prosthetic group to catalyze the oxidative cleavage of the indole ring of L-Trp, converting it to N-formylkynurenine (NFK) (Scheme 1). This is the first and rate-limiting step of the kynurenine pathway of L-Trp metabolism, which oxidizes over 99% of L-Trp in mammalian intracellular and extracellular pools (2, 4 -9). The kynurenine pathway constitutes the major steps in biosynthesis of NAD, an essential redox cofactor in all living systems (5).TDO is a hepatic enzyme first discovered in rat liver extracts in 1936 (1). An analogous enzyme, indoleamine 2,3-dioxygenase (IDO), was isolated 31 years later from tissues other than the liver (10). Although both enzymes catalyze the same reaction, TDO is highly substrate-specific with L-Trp, whereas IDO presents a more relaxed specificity. TDO is a homotetramer with a total mass of ϳ134 kDa, whereas IDO is a monomeric protein. The two enzymes share only 14% sequence identity but conserve similar active site architectures (11-13). In addition to humans, TDO has also been found in other mammals, such as rats and mice, as well as in mosquitoes and bacteria (2, 5, 14 -18). Recently, a potential heme-dependent dioxygenase enzyme superfamily has been proposed (19). Moreover, several other heme-based proteins, such as my...